Actavis Pharma’s commercial business in Europe is organized into seven clusters, including South Europe; the Nordics; Russia, Ukraine, CIS; Central Europe; the UK and Ireland; the Balkans; and Germany, Austria, Switzerland and the Benelux countries.

These clusters are designed to be roughly equal in size, combining countries with similar market structures and commercial dynamics. In addition, Actavis’ third-party business, Medis, is managed through the European region.